Year |
Citation |
Score |
2017 |
Li B, Shapiro PR, Rindler-Daller T. Bose-Einstein-condensed scalar field dark matter and the gravitational wave background from inflation: New cosmological constraints and its detectability by LIGO Physical Review D. 96. DOI: 10.1103/Physrevd.96.063505 |
0.44 |
|
2014 |
Li B, Rindler-Daller T, Shapiro PR. Cosmological constraints on Bose-Einstein-condensed scalar field dark matter Physical Review D - Particles, Fields, Gravitation and Cosmology. 89. DOI: 10.1103/Physrevd.89.083536 |
0.438 |
|
Low-probability matches (unlikely to be authored by this person) |
2005 |
Li B, Wang H, Dai J, Ji J, Qian W, Zhang D, Hou S, Guo Y. Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions. Immunology. 116: 487-98. PMID 16313362 DOI: 10.1111/j.1365-2567.2005.02247.x |
0.16 |
|
2016 |
Zhang Y, Wang L, Chong X, Yu X, Meng Y, Dong J, Wang C, Wang H, Yang Y, Xia T, Zhao J, Li B. A bispecific anti-ErbB2 antibody potently induces ErbB2 internalization and suppresses ErbB2-overexpressing tumor growth. Biochemical and Biophysical Research Communications. PMID 27363335 DOI: 10.1016/j.bbrc.2016.06.131 |
0.146 |
|
2009 |
Gao J, Zhong W, He J, Li H, Zhang H, Zhou G, Li B, Lu Y, Zou H, Kou G, Zhang D, Wang H, Guo Y, Zhong Y. Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes. International Journal of Pharmaceutics. 374: 145-52. PMID 19446771 DOI: 10.1016/j.ijpharm.2009.03.018 |
0.141 |
|
2011 |
Wang C, He X, Zhou B, Li J, Li B, Qian W, Hou S, Wang H, Shi Y, Guo Y. Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors. Mabs. 3: 67-75. PMID 21051930 |
0.141 |
|
2012 |
Li W, Zhao H, Qian W, Li H, Zhang L, Ye Z, Zhang G, Xia M, Li J, Gao J, Li B, Kou G, Dai J, Wang H, Guo Y. Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles. Biomaterials. 33: 5349-62. PMID 22542611 DOI: 10.1016/j.biomaterials.2012.04.016 |
0.141 |
|
2011 |
Li W, Li J, Gao J, Li B, Xia Y, Meng Y, Yu Y, Chen H, Dai J, Wang H, Guo Y. The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors. Biomaterials. 32: 3832-44. PMID 21377724 DOI: 10.1016/j.biomaterials.2011.01.075 |
0.139 |
|
2013 |
Gao J, Chen H, Song H, Su X, Niu F, Li W, Li B, Dai J, Wang H, Guo Y. Antibody-targeted immunoliposomes for cancer treatment. Mini Reviews in Medicinal Chemistry. 13: 2026-35. PMID 24251805 |
0.137 |
|
2016 |
Lu Q, Wang L, Zhang Y, Yu X, Wang C, Wang H, Yang Y, Chong X, Xia T, Meng Y, Wang Y, Lu C, Zhou L, Li B. An anti-ErbB2 fully human antibody circumvents trastuzumab resistance. Oncotarget. PMID 27564098 DOI: 10.18632/oncotarget.11562 |
0.135 |
|
2008 |
Li B, Shi S, Qian W, Zhao L, Zhang D, Hou S, Zheng L, Dai J, Zhao J, Wang H, Guo Y. Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity. Cancer Research. 68: 2400-8. PMID 18381448 DOI: 10.1158/0008-5472.CAN-07-6663 |
0.135 |
|
2016 |
Liu B, Guo H, Zhang J, Xue J, Yang Y, Qin T, Xu J, Guo Q, Zhang D, Qian W, Li B, Hou S, Dai J, Guo Y, Wang H. In-depth characterization of a pro-antibody-drug conjugate by LC-MS. Molecular Pharmaceutics. PMID 27377124 DOI: 10.1021/acs.molpharmaceut.6b00280 |
0.133 |
|
2009 |
Li B, Zhao L, Guo H, Wang C, Zhang X, Wu L, Chen L, Tong Q, Qian W, Wang H, Guo Y. Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma. Blood. 114: 5007-15. PMID 19828699 DOI: 10.1182/blood-2009-06-225474 |
0.133 |
|
2011 |
Gao J, Liu W, Xia Y, Li W, Sun J, Chen H, Li B, Zhang D, Qian W, Meng Y, Deng L, Wang H, Chen J, Guo Y. The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes. Biomaterials. 32: 3459-70. PMID 21296406 DOI: 10.1016/j.biomaterials.2011.01.034 |
0.133 |
|
2022 |
Zhong Z, Zhang M, Ning Y, Mao G, Li X, Deng Q, Chen X, Zuo D, Zhao X, Xie E, Wang H, Guo L, Li B, Xiao K, He X. Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity. Scientific Reports. 12: 18011. PMID 36289396 DOI: 10.1038/s41598-022-22975-7 |
0.133 |
|
2013 |
Li B, Meng Y, Zheng L, Zhang X, Tong Q, Tan W, Hu S, Li H, Chen Y, Song J, Zhang G, Zhao L, Zhang D, Hou S, Qian W, et al. Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization. Cancer Research. 73: 6471-83. PMID 24046294 DOI: 10.1158/0008-5472.CAN-13-0657 |
0.132 |
|
2010 |
Gao J, Sun J, Li H, Liu W, Zhang Y, Li B, Qian W, Wang H, Chen J, Guo Y. Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing. Biomaterials. 31: 2655-64. PMID 20035999 DOI: 10.1016/j.biomaterials.2009.11.112 |
0.13 |
|
2013 |
Zhao L, Tong Q, Qian W, Li B, Zhang D, Fu T, Duan S, Zhang X, Zhao J, Dai J, Wang H, Hou S, Guo Y. Eradication of non-Hodgkin lymphoma through the induction of tumor-specific T-cell immunity by CD20-Flex BiFP. Blood. 122: 4230-6. PMID 24178967 DOI: 10.1182/blood-2013-04-496554 |
0.13 |
|
2021 |
Wang C, Wang L, Liang B, Zhou B, Sun Y, Meng Y, Dong J, Chen L, Li B. Synergistic antitumor effect of the anti-ErbB2 antibodies trastuzumab and H2-18 on trastuzumab-resistant gastric cancer cells. Oncology Letters. 21: 400. PMID 33777223 DOI: 10.3892/ol.2021.12661 |
0.128 |
|
2008 |
Hou S, Li B, Wang L, Qian W, Zhang D, Hong X, Wang H, Guo Y. Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling. Journal of Biochemistry. 144: 115-20. PMID 18424812 DOI: 10.1093/jb/mvn052 |
0.128 |
|
2007 |
Li B, Wang H, Zhang D, Qian W, Hou S, Shi S, Zhao L, Kou G, Cao Z, Dai J, Guo Y. Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody. Biochemical and Biophysical Research Communications. 357: 951-6. PMID 17451647 DOI: 10.1016/j.bbrc.2007.04.039 |
0.128 |
|
2017 |
Yu X, Wang L, Shen Y, Wang C, Zhang Y, Meng Y, Yang Y, Liang B, Zhou B, Wang H, Wei H, Lei C, Hu S, Li B. Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibody. Molecular Immunology. 87: 300-307. PMID 28531814 DOI: 10.1016/j.molimm.2017.05.010 |
0.127 |
|
2011 |
Fan K, Zhang B, Yang H, Wang H, Tan M, Hou S, Qian W, Li B, Wang H, Dai J, Guo Y. A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice. European Journal of Pharmacology. 657: 144-51. PMID 21300057 DOI: 10.1016/j.ejphar.2011.01.041 |
0.126 |
|
2008 |
Cao Z, Dai J, Fan K, Wang H, Ji G, Li B, Zhang D, Hou S, Qian W, Zhao J, Wang H, Guo Y. A novel functional motif of osteopontin for human lymphocyte migration and survival. Molecular Immunology. 45: 3683-92. PMID 18632157 DOI: 10.1016/j.molimm.2008.06.008 |
0.126 |
|
2016 |
Wang L, Yu X, Dong J, Meng Y, Yang Y, Wang H, Wang C, Zhang Y, Zhao Y, Zhao J, Wang H, Lu C, Li B. Combined SRC inhibitor saracatinib and anti-ErbB2 antibody H2-18 produces a synergistic antitumor effect on trastuzumab-resistant breast cancer. Biochemical and Biophysical Research Communications. PMID 27666484 DOI: 10.1016/j.bbrc.2016.09.111 |
0.125 |
|
2007 |
Wang H, Song S, Kou G, Li B, Zhang D, Hou S, Qian W, Dai J, Tian L, Zhao J, Guo Y. Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome. Cancer Immunology, Immunotherapy : Cii. 56: 1775-83. PMID 17431617 DOI: 10.1007/s00262-007-0321-4 |
0.122 |
|
2015 |
Li H, Zhang G, Jiang C, Zhang F, Ke C, Zhao H, Sun Y, Zhao M, Chen D, Zhu X, Zhang L, Li B, Dai J, Li W. Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster. Oncotarget. PMID 26284588 |
0.122 |
|
2008 |
Fan K, Dai J, Wang H, Wei H, Cao Z, Hou S, Qian W, Wang H, Li B, Zhao J, Xu H, Yang C, Guo Y. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. Arthritis and Rheumatism. 58: 2041-52. PMID 18576331 DOI: 10.1002/art.23490 |
0.121 |
|
2016 |
Shi X, Deng Y, Wang H, Ji G, Tan W, Jiang T, Li X, Zhao H, Xia T, Meng Y, Wang C, Yu X, Yang Y, Li B, Qin ED, et al. A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion. Mabs. 0. PMID 26905804 DOI: 10.1080/19420862.2016.1148850 |
0.121 |
|
2012 |
Wang S, Chen C, Meng Y, Hu S, Zheng L, Song J, Zhang D, Li B, Guo Y. Effective suppression of breast tumor growth by an anti-EGFR/ErbB2 bispecific antibody. Cancer Letters. 325: 214-9. PMID 22789781 DOI: 10.1016/j.canlet.2012.07.007 |
0.121 |
|
2016 |
Yang Y, Guo Q, Chen X, Zhang J, Guo H, Qian W, Hou S, Dai J, Li B, Guo Y, Wang H. Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy. Mabs. 0. PMID 26760045 DOI: 10.1080/19420862.2015.1127491 |
0.121 |
|
2010 |
Li J, Zhou B, Shentu J, Du L, Tan M, Hou S, Qian W, Li B, Zhang D, Dai J, Wang H, Zhang X, Chen J, Guo Y. Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts. Mabs. 2: 449-56. PMID 20519962 DOI: 10.4161/mabs.12305 |
0.12 |
|
2014 |
Zhao L, Xie F, Tong X, Li H, Chen Y, Qian W, Duan S, Zheng J, Zhao Z, Li B, Zhang D, Zhao J, Dai J, Wang H, Hou S, et al. Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMab. Mabs. 6: 740-8. PMID 24670986 DOI: 10.4161/mabs.28613 |
0.119 |
|
2007 |
Du J, Wang H, Zhong C, Peng B, Zhang M, Li B, Huo S, Guo Y, Ding J. Structural basis for recognition of CD20 by therapeutic antibody Rituximab. The Journal of Biological Chemistry. 282: 15073-80. PMID 17395584 DOI: 10.1074/Jbc.M701654200 |
0.119 |
|
2019 |
Li T, Zhou D, Xu X, Qu J, Jiang C, Lan H, Lou W, Chen W, Jin L, Liu R, Liu Z, Zhang C, Duan L, Li B, Xu J, et al. Effect of Traditional Chinese Medicine plus narrow-band medium-wave ultraviolet B radiation on moderate-to-severe psoriasis vulgaris in a case series. Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan. 39: 692-699. PMID 32186119 |
0.119 |
|
2009 |
Gao J, Li B, Li H, Zhang X, Zhang D, Zhao L, Wang C, Fang C, Qian W, Hou S, Kou G, Wei H, Shi S, Wang H, Guo Y. Development and characterization of a fully functional small anti-HER2 antibody. Bmb Reports. 42: 636-41. PMID 19874707 DOI: 10.5483/BMBREP.2009.42.10.636 |
0.118 |
|
2007 |
Fan K, Wang H, Wei H, Zhou Q, Kou G, Hou S, Qian W, Dai J, Li B, Zhang Y, Zhu T, Guo Y. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance. Transplantation. 84: 746-54. PMID 17893608 DOI: 10.1097/01.tp.0000280545.14489.df |
0.118 |
|
2010 |
Dai J, Li B, Shi J, Peng L, Zhang D, Qian W, Hou S, Zhao L, Gao J, Cao Z, Zhao J, Wang H, Guo Y. A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo. Cancer Immunology, Immunotherapy : Cii. 59: 355-66. PMID 19690854 DOI: 10.1007/s00262-009-0754-z |
0.118 |
|
2017 |
Wang L, Yu X, Wang C, Pan S, Liang B, Zhang Y, Chong X, Meng Y, Dong J, Zhao Y, Yang Y, Wang H, Gao J, Wei H, Zhao J, ... ... Li B, et al. The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer. Oncotarget. 8: 52877-52888. PMID 28881779 DOI: 10.18632/oncotarget.17907 |
0.117 |
|
2017 |
Wang L, Yu X, Wang C, Pan S, Liang B, Zhang Y, Chong X, Meng Y, Dong J, Zhao Y, Yang Y, Wang H, Gao J, Wei H, Zhao J, ... ... Li B, et al. The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer. Oncotarget. PMID 28572529 DOI: 10.18632/oncotarget.17907 |
0.117 |
|
2007 |
Hou S, Kou G, Fan X, Wang H, Qian W, Zhang D, Li B, Dai J, Zhao J, Ma J, Li J, Lin B, Wu M, Guo Y. Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU. Cancer Immunology, Immunotherapy : Cii. 56: 1605-13. PMID 17361437 DOI: 10.1007/s00262-007-0306-3 |
0.116 |
|
2005 |
Wang H, Dai J, Hou S, Qian W, Li B, Ma J, Fan X, Zhao J, Yang S, Sang H, Yang Q, Wang R, Guo Y. Treatment of hepatocellular carcinoma with adenoviral vector-mediated Flt3 ligand gene therapy. Cancer Gene Therapy. 12: 769-77. PMID 15877081 DOI: 10.1038/sj.cgt.7700843 |
0.115 |
|
2008 |
Qian W, Wang L, Li B, Wang H, Hou S, Hong X, Zhang D, Guo Y. Development of new versions of anti-human CD34 monoclonal antibodies with potentially reduced immunogenicity. Biochemical and Biophysical Research Communications. 367: 497-502. PMID 18190781 DOI: 10.1016/j.bbrc.2007.12.184 |
0.115 |
|
2008 |
Wang H, Dai J, Li B, Fan K, Peng L, Zhang D, Cao Z, Qian W, Wang H, Zhao J, Guo Y. Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A. Protein Expression and Purification. 58: 140-7. PMID 17950620 DOI: 10.1016/j.pep.2007.09.009 |
0.113 |
|
2015 |
Chen Y, Chen L, Lu Q, Meng Y, Wang C, Wang L, Wang H, Yu X, Zhang Y, Zhao L, Li B, Guo Y. Optimization of anti-CD20 humanized antibody hu8E4 by site-directed mutation based on epitope analysis. Biochemical and Biophysical Research Communications. 459: 617-22. PMID 25749344 DOI: 10.1016/j.bbrc.2015.02.158 |
0.113 |
|
2014 |
Han S, Meng Y, Tong Q, Li G, Zhang X, Chen Y, Hu S, Zheng L, Tan W, Li H, Chen Y, Zhang G, Li B, Guo Y. The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancer. Mabs. 6: 403-8. PMID 24492292 DOI: 10.4161/mabs.27443 |
0.111 |
|
2017 |
Wang C, Wang L, Yu X, Zhang Y, Meng Y, Wang H, Yang Y, Gao J, Wei H, Zhao J, Lu C, Chen H, Sun Y, Li B. Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody. Oncotarget. PMID 28514745 DOI: 10.18632/oncotarget.17451 |
0.108 |
|
2010 |
Wu L, Wang C, Zhang D, Zhang X, Qian W, Zhao L, Wang H, Li B, Guo Y. Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma. Cancer Letters. 292: 208-14. PMID 20056316 DOI: 10.1016/j.canlet.2009.12.004 |
0.106 |
|
2007 |
Hu S, Dai J, Wei H, Fan K, Wang H, Zhang D, Qian W, Li B, Wang H, Zhu T, Zhang Y, Guo Y. Functional and stable expression of recombinant human FOXP3 in bacterial cells and development of antigen-specific monoclonal antibodies. Journal of Biochemistry. 142: 471-80. PMID 17761693 DOI: 10.1093/Jb/Mvm160 |
0.106 |
|
2012 |
Tan Q, Guo Q, Fang C, Wang C, Li B, Wang H, Li J, Guo Y. Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products. Mabs. 4: 761-74. PMID 23032066 DOI: 10.4161/mabs.22276 |
0.105 |
|
2007 |
Dai J, Jin J, Li B, Wang H, Hou S, Qian W, Kou G, Zhang D, Li J, Tan M, Ma J, Guo Y. A chimeric SM5-1 antibody inhibits hepatocellular carcinoma cell growth and induces caspase-dependent apoptosis. Cancer Letters. 258: 208-14. PMID 17959303 DOI: 10.1016/j.canlet.2007.09.002 |
0.104 |
|
2008 |
Du J, Wang H, Zhong C, Peng B, Zhang M, Li B, Hou S, Guo Y, Ding J. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide. Molecular Immunology. 45: 2861-8. PMID 18346788 DOI: 10.1016/J.Molimm.2008.01.034 |
0.103 |
|
2016 |
Li Y, Fu T, Liu T, Guo H, Guo Q, Xu J, Zhang D, Qian W, Dai J, Li B, Guo Y, Hou S, Wang H. Characterization of alanine to valine sequence variants in the Fc region of nivolumab biosimilar produced in Chinese hamster ovary cells. Mabs. 0. PMID 27050807 DOI: 10.1080/19420862.2016.1172150 |
0.102 |
|
2010 |
Li B, Zhao L, Wang C, Guo H, Wu L, Zhang X, Qian W, Wang H, Guo Y. The protein-protein interface evolution acts in a similar way to antibody affinity maturation. The Journal of Biological Chemistry. 285: 3865-71. PMID 20007707 DOI: 10.1074/jbc.M109.076547 |
0.097 |
|
2010 |
Pang MS, Chen X, Lu B, Zhao J, Li BH, Wei YQ, Guo YJ. Lentiviral vector-mediated doxycycline-inducible iASPP gene targeted RNA interference in hepatocellular carcinoma. Chinese Journal of Cancer. 29: 796-801. PMID 20800021 |
0.097 |
|
2016 |
Chen R, Wang H, Liang B, Liu G, Tang M, Jia R, Fan X, Jing W, Zhou X, Wang H, Yang Y, Wei H, Li B, Zhao J. Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation. Cell Death & Disease. 7: e2512. PMID 27929538 DOI: 10.1038/cddis.2016.407 |
0.096 |
|
2009 |
Wang H, Wei H, Zhang R, Hou S, Li B, Qian W, Zhang D, Kou G, Dai J, Guo Y. Genetically targeted T cells eradicate established breast cancer in syngeneic mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 943-50. PMID 19188165 DOI: 10.1158/1078-0432.CCR-08-2381 |
0.096 |
|
2013 |
Li W, Zhang L, Zhang G, Wei H, Zhao M, Li H, Guo S, Gao J, Kou G, Li B, Dai J, Wang H, Guo Y. The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy. Mini Reviews in Medicinal Chemistry. 13: 643-52. PMID 23469780 |
0.095 |
|
2024 |
Yuwen H, Wang H, Li T, Ren Y, Zhang YK, Chen P, Sun A, Bian G, Li B, Flowers D, Presler M, Subramanian K, Xue J, Wang J, Lynch K, et al. ATG-101 is a tetravalent PD-L1×4-1BB bispecific antibody that stimulates anti-tumor immunity through PD-L1 blockade and PD-L1-directed 4-1BB activation. Cancer Research. PMID 38501978 DOI: 10.1158/0008-5472.CAN-23-2701 |
0.094 |
|
2017 |
Ma H, Chen S, He Y, Huang J, Xu Y, Wang C, Lei C, Lu T, Xiao S, Mao J, Xu Y, Guo H, Li B, Zhang M, He X. Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment. Protein & Cell. PMID 29143211 DOI: 10.1007/s13238-017-0489-0 |
0.094 |
|
2017 |
Wu L, Deng Z, Peng Y, Han L, Liu J, Wang L, Li B, Zhao J, Jiao S, Wei H. Ascites-derived IL-6 and IL-10 synergistically expand CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in ovarian cancer patients. Oncotarget. 8: 76843-76856. PMID 29100353 DOI: 10.18632/oncotarget.20164 |
0.093 |
|
2010 |
Dai J, Li B, Shi J, Peng L, Zhang D, Qian W, Hou S, Zhao L, Gao J, Cao Z, Zhao J, Wang H, Guo Y. Erratum to: A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo Cancer Immunology, Immunotherapy. 59: 641-642. DOI: 10.1007/s00262-009-0812-6 |
0.092 |
|
2021 |
Zhong Z, Yang Y, Chen X, Han Z, Zhou J, Li B, He X. Positive charge in the complementarity-determining regions of synthetic nanobody prevents aggregation. Biochemical and Biophysical Research Communications. 572: 1-6. PMID 34332323 DOI: 10.1016/j.bbrc.2021.07.054 |
0.09 |
|
2016 |
Jia R, Liang Y, Chen R, Liu G, Wang H, Tang M, Zhou X, Wang H, Yang Y, Wei H, Li B, Song Y, Zhao J. Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity. Cell Death & Disease. 7: e2564. PMID 28032860 DOI: 10.1038/cddis.2016.422 |
0.09 |
|
2007 |
Kou G, Shi S, Wang H, Tan M, Xue J, Zhang D, Hou S, Qian W, Wang S, Dai J, Li B, Guo Y. Preparation and characterization of recombinant protein ScFv(CD11c)-TRP2 for tumor therapy from inclusion bodies in Escherichia coli. Protein Expression and Purification. 52: 131-8. PMID 17027283 DOI: 10.1016/j.pep.2006.08.007 |
0.089 |
|
2012 |
Zhou B, Lin B, Li J, Qian W, Hou S, Zhang D, Kou G, Li B, Wang H, Chen Y, Guo Y. Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjects. Mabs. 4: 110-9. PMID 22327434 DOI: 10.4161/mabs.4.1.18349 |
0.089 |
|
2011 |
Dai J, Zhao L, Yang H, Guo H, Fan K, Wang H, Qian W, Zhang D, Li B, Wang H, Guo Y. Identification of a novel functional domain of ricin responsible for its potent toxicity. The Journal of Biological Chemistry. 286: 12166-71. PMID 21303906 DOI: 10.1074/jbc.M110.196584 |
0.089 |
|
2010 |
Kou G, Shi J, Chen L, Zhang D, Hou S, Zhao L, Fang C, Zheng L, Zhang X, Liang P, Zhang X, Li B, Guo Y. A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin. Cancer Letters. 299: 130-6. PMID 20826049 DOI: 10.1016/j.canlet.2010.08.011 |
0.088 |
|
2015 |
Hu S, Sun Y, Meng Y, Wang X, Yang W, Fu W, Guo H, Qian W, Hou S, Li B, Rao Z, Lou Z, Guo Y. Molecular architecture of the ErbB2 extracellular domain homodimer. Oncotarget. 6: 1695-706. PMID 25633808 |
0.088 |
|
2009 |
Li J, Li X, Tan M, Lin B, Hou S, Qian W, Li B, Zhang D, Zhou B, Wang H, Zhu T, Guo Y. Two doses of humanized anti-CD25 antibody in renal transplantation: a preliminary comparative study. Mabs. 1: 49-55. PMID 20046574 DOI: 10.4161/mabs.1.1.7399 |
0.088 |
|
2013 |
Tan W, Meng Y, Li H, Chen Y, Han S, Zeng J, Huang A, Li B, Zhang Y, Guo Y. A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity. Mabs. 5: 946-55. PMID 24492346 DOI: 10.4161/mabs.26390 |
0.086 |
|
2010 |
Qian W, Zhang X, Li B, Zhang D, Tong Q, Chen L, Zheng L, Kou G, Wang H, Hou S, Guo Y. Development and characterization of a novel anti-IgE monoclonal antibody. Biochemical and Biophysical Research Communications. 395: 547-52. PMID 20394728 DOI: 10.1016/j.bbrc.2010.04.063 |
0.084 |
|
2008 |
Zheng L, Li B, Qian W, Zhao L, Cao Z, Shi S, Gao J, Zhang D, Hou S, Dai J, Wang H, Guo Y. Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab. Biochemical and Biophysical Research Communications. 375: 619-22. PMID 18725193 DOI: 10.1016/j.bbrc.2008.08.055 |
0.083 |
|
2016 |
Liu B, Guo H, Xu J, Qin T, Xu L, Zhang J, Guo Q, Zhang D, Qian W, Li B, Dai J, Hou S, Guo Y, Wang H. Acid-induced aggregation propensity of nivolumab is dependent on the Fc. Mabs. 0. PMID 27310175 DOI: 10.1080/19420862.2016.1197443 |
0.082 |
|
2008 |
Kou G, Wang S, Cheng C, Gao J, Li B, Wang H, Qian W, Hou S, Zhang D, Dai J, Gu H, Guo Y. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection. Biochemical and Biophysical Research Communications. 374: 192-7. PMID 18621023 DOI: 10.1016/j.bbrc.2008.06.126 |
0.082 |
|
2008 |
Wei H, Wang H, Lu B, Li B, Hou S, Qian W, Fan K, Dai J, Zhao J, Guo Y. Cancer immunotherapy using in vitro genetically modified targeted dendritic cells. Cancer Research. 68: 3854-62. PMID 18483270 DOI: 10.1158/0008-5472.CAN-07-6051 |
0.081 |
|
2023 |
Chen N, Gui B, Yang B, Deng C, Liang Y, Zhang F, Li B, Sun W, Wu F, Chen R. LiPF Induces Phosphorization of Garnet-Type Solid-State Electrolyte for Stable Lithium Metal Batteries. Small (Weinheim An Der Bergstrasse, Germany). e2305576. PMID 37821400 DOI: 10.1002/smll.202305576 |
0.081 |
|
2015 |
Song H, Su X, Yang K, Niu F, Li J, Song J, Chen H, Li B, Li W, Qian W, Cao X, Guo S, Dai J, Feng SS, Guo Y, et al. CD20 Antibody-Conjugated Immunoliposomes for Targeted Chemotherapy of Melanoma Cancer Initiating Cells. Journal of Biomedical Nanotechnology. 11: 1927-46. PMID 26554153 DOI: 10.1166/jbn.2015.2129 |
0.081 |
|
2022 |
Chen C, Zhao X, Luo Y, Li B, Li Q, Zhao C, Huang Y, Kang P. Imbalanced T-Cell Subsets May Facilitate the Occurrence of Osteonecrosis of the Femoral Head. Journal of Inflammation Research. 15: 4159-4169. PMID 35912401 DOI: 10.2147/JIR.S367214 |
0.08 |
|
2015 |
Li H, Xu Z, Wu C, Zhao H, Zhang G, Wang H, Ke C, Li B, Guo Y. WITHDRAWN: Effective suppression of Rituximab-resistant B-cell lymphoma by a comb-like anti-CD20 mAb nanocluster. Cancer Letters. PMID 25721087 DOI: 10.1016/j.canlet.2015.02.025 |
0.078 |
|
2013 |
Zhang CC, Ye JT, Zhang YP, Liao JK, Li BH. Effect of titanium preoxidation on wrought pure titanium to ceramic bond strength. The Journal of Prosthetic Dentistry. 109: 106-12. PMID 23395336 DOI: 10.1016/S0022-3913(13)60025-6 |
0.077 |
|
2016 |
Liu G, Fan X, Tang M, Chen R, Wang H, Jia R, Zhou X, Jing W, Wang H, Yang Y, Yin F, Wei H, Li B, Zhao J. Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells. Cancer Letters. PMID 27702661 DOI: 10.1016/j.canlet.2016.09.033 |
0.076 |
|
2012 |
Li XP, Li J, Yan H, Zhou B, Li BH, Qian WZ, Hou S, Wang H, Hao F, Guo YJ. Tolerability, pharmacokinetics and pharmacodynamics of CMAB001, an anti-CD11a antibody, in Chinese healthy volunteers and psoriatic patients. Acta Pharmacologica Sinica. 33: 1085-94. PMID 22796761 DOI: 10.1038/aps.2012.65 |
0.075 |
|
2010 |
Li B, Zhang X, Shi S, Zhao L, Zhang D, Qian W, Zheng L, Gao J, Wang H, Guo Y. Construction and characterization of a bispecific anti-CD20 antibody with potent antitumor activity against B-cell lymphoma. Cancer Research. 70: 6293-302. PMID 20631068 DOI: 10.1158/0008-5472.CAN-10-0009 |
0.074 |
|
2018 |
Li BH, Wang SX, Li J, Huang FG, Xiang Z, Fang Y, Zhong G, Yi M, Zhao XD, Liu L. Early and mid-term results of transarticular external fixation in the treatment of supination-external rotation type IV equivalent ankle fractures. Chinese Journal of Traumatology = Zhonghua Chuang Shang Za Zhi. PMID 30017542 DOI: 10.1016/j.cjtee.2018.03.004 |
0.073 |
|
2010 |
Zhang D, Li B, Shi J, Zhao L, Zhang X, Wang C, Hou S, Qian W, Kou G, Wang H, Guo Y. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Cancer Research. 70: 2495-503. PMID 20197464 DOI: 10.1158/0008-5472.CAN-09-3488 |
0.073 |
|
2010 |
Wang YF, Li BH, Zhang M, Xu WB, Zhou R, Zhou M. [Stage-based treatment of gouty arthritis by combination therapy of traditional Chinese and Western medicines: a randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine. 6: 576-80. PMID 18559233 DOI: 10.3736/jcim20080606 |
0.067 |
|
2015 |
Mao X, Liu J, Gong Z, Zhang H, Lu Y, Zou H, Yu Y, Chen Y, Sun Z, Li W, Li B, Gao J, Zhong Y. iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells. Nanomedicine (London, England). PMID 26355733 DOI: 10.2217/nnm.15.106 |
0.064 |
|
2009 |
Ma Y, Lin BR, Lin B, Hou S, Qian WZ, Li J, Tan M, Ma J, Li BH, Wang H, Wen AD, Guo YJ. Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis. Acta Pharmacologica Sinica. 30: 364-71. PMID 19262560 DOI: 10.1038/aps.2009.13 |
0.062 |
|
2016 |
Xie F, Zhang S, Liu J, Gong Z, Yang K, Zhang H, Lu Y, Zou H, Yu Y, Chen Y, Sun Z, Wang X, Zhang H, Zhang G, Li W, ... Li B, et al. Codelivery of salinomycin and chloroquine by liposomes enables synergistic antitumor activity in vitro. Nanomedicine (London, England). PMID 27391366 DOI: 10.2217/nnm-2016-0125 |
0.062 |
|
2019 |
Li J, Huang Z, Li B, Zhang Z, Liu L. Mobilization of Transplanted Bone Marrow Mesenchymal Stem Cells by Erythropoietin Facilitates the Reconstruction of Segmental Bone Defect. Stem Cells International. 2019: 5750967. PMID 31065275 DOI: 10.1155/2019/5750967 |
0.062 |
|
2017 |
Huang Y, Zhang Y, Fan K, Dong G, Li B, Zhang W, Li J, Sheng C. Discovery of new Syk inhibitors through structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters. PMID 28268139 DOI: 10.1016/j.bmcl.2017.02.060 |
0.06 |
|
2007 |
Kou G, Gao J, Wang H, Chen H, Li B, Zhang D, Wang S, Hou S, Qian W, Dai J, Zhong Y, Guo Y. Preparation and Characterization of Paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibody. Journal of Biochemistry and Molecular Biology. 40: 731-9. PMID 17927907 DOI: 10.5483/BMBREP.2007.40.5.731 |
0.057 |
|
2016 |
Yang K, Lu Y, Xie F, Zou H, Fan X, Li B, Li W, Zhang W, Mei L, Feng SS, Yin Y, Liu Y, Zhang H, Yin C, Zhong Y, et al. Cationic liposomes induce cell necrosis through lysosomal dysfunction and late-stage autophagic flux inhibition. Nanomedicine (London, England). PMID 27819530 DOI: 10.2217/nnm-2016-0289 |
0.056 |
|
2023 |
Zhang F, Lai J, Hu Z, Zhou A, Wang H, Hu X, Hou L, Li B, Sun W, Chen N, Li L, Wu F, Chen R. Lithium Salt Dissociation Promoted by 18-Crown-6 Ether Additive toward Dilute Electrolytes for High Performance Lithium Oxygen Batteries. Angewandte Chemie (International Ed. in English). e202301772. PMID 36807435 DOI: 10.1002/anie.202301772 |
0.056 |
|
2009 |
Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4612-21. PMID 19584156 DOI: 10.1158/1078-0432.CCR-08-3321 |
0.056 |
|
2022 |
Wang S, Li B, Yu X, Wu H, Liu L. Is Ankle Arthrodesis With an Ilizarov External Fixator an Effective Treatment for Septic Ankle Arthritis? A Study With a Minimum of 6 Years of Follow-up. Clinical Orthopaedics and Related Research. PMID 36136051 DOI: 10.1097/CORR.0000000000002418 |
0.055 |
|
2022 |
Li J, Li M, Wang W, Li B, Liu L. Evolution and Development of Ilizarov Technique in the Treatment of Infected Long Bone Nonunion with or without Bone Defects. Orthopaedic Surgery. PMID 35343060 DOI: 10.1111/os.13218 |
0.053 |
|
2015 |
Li J, Ye X, Li B, Liao J, Zhuang P, Ye J. Effect of oxidation heat treatment on the bond strength between a ceramic and cast and milled cobalt-chromium alloys. European Journal of Oral Sciences. PMID 26104804 DOI: 10.1111/eos.12199 |
0.052 |
|
2022 |
Li W, Li BH, Ya XX, Zhu HT, Zhou DM. [Experience of 's three-clear method by stages for herpes zoster on the head and face]. Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion. 42: 1041-3. PMID 36075602 DOI: 10.13703/j.0255-2930.20210923-k0003 |
0.051 |
|
2021 |
Li B, Shi L, Liu R, Li Z, Cao S, Li J. A lingering mouthwash with sustained antibiotic release and biofilm eradication for periodontitis. Journal of Materials Chemistry. B. 9: 8694-8707. PMID 34622266 DOI: 10.1039/d1tb01742j |
0.05 |
|
2024 |
Jiang Y, Duan X, Li B, Lu S, Liu T, Li Y. Synergistic Activation of Electric Furnace Ferronickel Slag by Mechanical Grinding and Chemical Activators to Prepare Cementitious Composites. Materials (Basel, Switzerland). 17. PMID 38541400 DOI: 10.3390/ma17061247 |
0.049 |
|
2009 |
Gao J, Kou G, Wang H, Chen H, Li B, Lu Y, Zhang D, Wang S, Hou S, Qian W, Dai J, Zhao J, Zhong Y, Guo Y. PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity. Breast Cancer Research and Treatment. 115: 29-41. PMID 18481173 DOI: 10.1007/s10549-008-0043-0 |
0.048 |
|
2017 |
Li J, Li B, Zhang Z, Wang S, Liu L. Ilizarov external fixation versus plate internal fixation in the treatment of end-stage ankle arthritis: decision analysis of clinical parameters. Scientific Reports. 7: 16155. PMID 29170505 DOI: 10.1038/s41598-017-16473-4 |
0.048 |
|
2019 |
Li B, Wang S, Zhang Z, Yang H, Li J, Li Q, Liu L. Transarticular external fixation versus deltoid ligament repair in treating SER IV ankle fractures: a comparative study. Bmc Musculoskeletal Disorders. 20: 453. PMID 31627717 DOI: 10.1186/s12891-019-2840-5 |
0.047 |
|
2015 |
Su X, Song H, Niu F, Yang K, Kou G, Wang X, Chen H, Li W, Guo S, Li J, Li B, Feng SS, Jiang J, Yin C, Gao J. Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. Nanomedicine (London, England). 10: 2033-50. PMID 26084553 DOI: 10.2217/nnm.15.50 |
0.047 |
|
2022 |
Li J, Wang W, Yang H, Li B, Liu L. Management of Elderly Traumatic Ankle Arthritis with Ilizarov External Fixation. Orthopaedic Surgery. PMID 36001696 DOI: 10.1111/os.13399 |
0.046 |
|
2019 |
Chen Z, Zhou D, Wang Y, Lan H, Duan X, Li B, Zhao J, Li W, Liu Z, Di T, Guo X, Zhang J, Li B, Feng S, Li P. Fire needle acupuncture or moxibustion for chronic plaque psoriasis: study protocol for a randomized controlled trial. Trials. 20: 674. PMID 31801593 DOI: 10.1186/s13063-019-3736-2 |
0.045 |
|
2021 |
Wang S, Li B, Zhang Z, Yu X, Li Q, Liu L. Early versus delayed hip reduction in the surgical treatment of femoral head fracture combined with posterior hip dislocation: a comparative study. Bmc Musculoskeletal Disorders. 22: 1057. PMID 34930251 DOI: 10.1186/s12891-021-04968-1 |
0.044 |
|
2021 |
Li B, Lei Y, Hu Q, Li D, Zhao H, Kang P. Porous copper- and lithium- doped nano-hydroxyapatite composite scaffold promotes angiogenesis and bone regeneration in the repair of glucocorticoids-induced osteonecrosis of the femoral head. Biomedical Materials (Bristol, England). PMID 34492640 DOI: 10.1088/1748-605X/ac246e |
0.041 |
|
2018 |
Wang S, Li B, Li J, Huang F, Xiang Z, Zhong G, Fang Y, Yi M, Zhao X, Liu L. Middle-term follow-up results of Pipkin type IV femoral head fracture patients treated by reconstruction plate and bioabsorbable screws. Chinese Journal of Traumatology = Zhonghua Chuang Shang Za Zhi. PMID 29793730 DOI: 10.1016/j.cjtee.2017.12.004 |
0.037 |
|
2018 |
Li B, Li J, Wang S, Liu L. Clinical analysis of peri-operative hidden blood loss of elderly patients with intertrochanteric fractures treated by unreamed proximal femoral nail anti-rotation. Scientific Reports. 8: 3225. PMID 29459684 DOI: 10.1038/s41598-018-21703-4 |
0.037 |
|
2011 |
Liao JK, Ye JT, Zhu F, Zhang CC, Wen XS, Zhang YP, Li BH. [Effect of different heat treatment on the bonding strength of porcelain and Co-Cr alloy]. Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology. 20: 567-71. PMID 22241301 |
0.037 |
|
2016 |
Pan F, Mao H, Bu F, Tong X, Li J, Zhang S, Liu X, Wang L, Wu L, Chen R, Wei H, Li B, Li C, Yang Y, Steer CJ, et al. Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma. Oncotarget. PMID 27974696 DOI: 10.18632/oncotarget.13902 |
0.035 |
|
2021 |
Chen ZX, Li P, Zhang GZ, Li B, Hu J, Feng S, Li BH, Lv JJ, Guo XW, Zhao JX, Di TT, Feng F, Wang Y. [Moxibustion on plaque psoriasis of blood stasis: a randomized controlled trial]. Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion. 41: 762-6. PMID 34259409 DOI: 10.13703/j.0255-2930.20200907-0004 |
0.034 |
|
2022 |
Zhang Z, Liu P, Wang W, Wang S, Li B, Li J, Yang B, Li M, Li Q, Yang H, Huang Z, Liu L. Epidemiology and Drug Resistance of Fracture-Related Infection of the Long Bones of the Extremities: A Retrospective Study at the Largest Trauma Center in Southwest China. Frontiers in Microbiology. 13: 923735. PMID 35903480 DOI: 10.3389/fmicb.2022.923735 |
0.032 |
|
2008 |
Gao J, Kou G, Chen H, Wang H, Li B, Lu Y, Zhang D, Wang S, Hou S, Qian W, Dai J, Zhao J, Zhong Y, Guo Y. Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab') fragments. Molecular Cancer Therapeutics. 7: 3399-407. PMID 18852143 DOI: 10.1158/1535-7163.MCT-08-0514 |
0.031 |
|
2022 |
Li B, Wang S, Li Q, Zhang Z, Li J, Yang H, Liu L. Effectiveness of Ilizarov Ankle Arthrodesis in the Treatment of End-Stage Varus Ankle Osteoarthritis: A Retrospective Study. Orthopaedic Surgery. PMID 35441475 DOI: 10.1111/os.13286 |
0.029 |
|
2012 |
Li W, Guo Q, Zhao H, Zhang L, Li J, Gao J, Qian W, Li B, Chen H, Wang H, Dai J, Guo Y. Novel dual-control poly(N-isopropylacrylamide-co-chlorophyllin) nanogels for improving drug release. Nanomedicine (London, England). 7: 383-92. PMID 22385198 DOI: 10.2217/nnm.11.100 |
0.027 |
|
2023 |
Wang S, Yu X, Li B, Ding Q, Wang T, Li Q, Liu L, Wu H. Pipkin type III femoral head fracture: which treatment strategy can be recommended? Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology. 24: 28. PMID 37328665 DOI: 10.1186/s10195-023-00701-x |
0.027 |
|
2014 |
Li BH, Ye JT, Liao JK, Zhuang PL, Zhang YP, Li JY. Effect of pretreatments on the metal-ceramic bonding strength of a Pd-Ag alloy. Journal of Dentistry. 42: 319-28. PMID 24316343 DOI: 10.1016/j.jdent.2013.11.020 |
0.027 |
|
2019 |
Wang S, Li B, Li J, Zhang Z, Yang H, Liu L. Comparison of the modified Heuter approach and the Kocher-Langenbeck approach in the treatment of Pipkin type I and type II femoral head fractures. International Orthopaedics. PMID 30683993 DOI: 10.1007/s00264-019-04301-5 |
0.024 |
|
2010 |
Zhang Y, Li H, Sun J, Gao J, Liu W, Li B, Guo Y, Chen J. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. International Journal of Pharmaceutics. 390: 198-207. PMID 20116418 DOI: 10.1016/j.ijpharm.2010.01.035 |
0.023 |
|
2014 |
Tian X, Wu J, Li B, Qin M, Qi J. [Occurrence of cesarean section and related factors in 40 counties of China from 1978 to 2010]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]. 48: 391-5. PMID 24985379 |
0.023 |
|
2007 |
Zhao FM, Guo SF, Li BH, Cui Y, Wu KS. [Survey on the situation of antenatal care in different regions of China, in 1971 - 2003]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. 26: 172-6. PMID 15941499 |
0.022 |
|
2023 |
Sun Y, Lin Y, Li Q, Li B, Wang D, Huang X. [Effectiveness of preemptive analgesia with imrecoxib on analgesia after anterior cruciate ligament reconstruction: a randomized controlled study]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery. 37: 982-988. PMID 37586799 DOI: 10.7507/1002-1892.202304068 |
0.018 |
|
2017 |
Li B, Huang F, Liu L. [Progress of treatments for old calcaneal fractures]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery. 31: 1273-1277. PMID 29806334 DOI: 10.7507/1002-1892.201703108 |
0.018 |
|
2008 |
Li XP, Li J, Yan H, Hou S, Qian WZ, Chen YC, Tang M, Li BH, Zhang DP, Zhou B, Wang H, Hao F, Guo YJ. Pharmacokinetic and pharmacodynamic study of LFA3Ig fusion protein in healthy volunteers and patients with psoriasis. Acta Pharmacologica Sinica. 29: 1077-85. PMID 18718177 DOI: 10.1111/j.1745-7254.2008.00832.x |
0.013 |
|
2020 |
Wang Y, Li B, Li P, Gong T, Wu M, Fu J, Nie M, Dong Y, Hu K. Severe obstructive sleep apnea in patients with chronic obstructive pulmonary disease is associated with an increased prevalence of mild cognitive impairment. Sleep Medicine. PMID 32828695 DOI: 10.1016/j.sleep.2020.05.002 |
0.01 |
|
2006 |
Stones RW, Padmadas SS, Guo S, Brown JJ, Zhao F, Li B. Dyspareunia, urinary sensory symptoms, and incontinence among young Chinese women. Archives of Sexual Behavior. 35: 561-7. PMID 17031583 DOI: 10.1007/s10508-006-9070-2 |
0.01 |
|
Hide low-probability matches. |